2 Years
9 Years
Both
Pervasive Child Development Disorders, Autism
Trial Information
PROTOCOL OUTLINE:
Patients are evaluated with the following questionnaires at ages 2-3 years and again at ages
5-9: The Autism Diagnostic Interview (ADI); The Autism Diagnostic Observation Schedule
(ADOS); Assessment of cognitive functioning; Expressive and receptive language; Adaptive
functioning; Measures of burden and functional assessment; The Aberrant Behavior Checklist;
The Connors Rating Scale - Parent and Teacher version; and Autism Behavior Checklist
An MRI and EEG are performed, and blood samples are collected from patients and family
members for molecular genetic studies.
Inclusion Criteria
- Psychologically diagnosed (DSM-IV) as Childhood Disintegrative Disorder
- No known genetic or medical syndrome (Down syndrome or cerebral palsy)
- Must speak English
Type of Study:
Observational
Study Design:
Primary Purpose: Screening, Time Perspective: Longitudinal
Principal Investigator
Fred Volkmar
Investigator Role:
Study Chair
Investigator Affiliation:
Yale University
Authority:
United States: Federal Government
Study ID:
199/13682
NCT ID:
NCT00004458
Start Date:
May 1997
Completion Date:
Related Keywords:
- Pervasive Child Development Disorders
- Autism
- autism
- childhood disintegrative disorder
- neurologic and psychiatric disorders
- rare disease
- Autistic Disorder
- Developmental Disabilities
- Child Development Disorders, Pervasive
Name | Location |
|---|---|
| University of Chicago Cancer Research Center | Chicago, Illinois 60637 |
| Yale Child Study Center | New Haven, Connecticut 06520 |
